Amelioration of behavioural, biochemical, and neurophysiological deficits by combination of monosodium glutamate with resveratrol/alpha-lipoic acid/coenzyme Q10 in rat model of cisplatin-induced peripheral neuropathy

The Scientific World Journal

Volumn 2013, Issue , 2013, Pages

  Bhadri, Naini ^a   Sanji, Tejaswi ^a   Madakasira Guggilla, Hariprasad ^a   Razdan, Rema ^a  

^a AL AMEEN COLLEGE OF PHARMACY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CATALASE; CISPLATIN; GLUTAMATE SODIUM; GLUTATHIONE; RESVERATROL; THIOCTIC ACID; UBIDECARENONE; DRUG DERIVATIVE; NEUROPROTECTIVE AGENT; STILBENE DERIVATIVE; UBIQUINONE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; BRAIN ELECTROPHYSIOLOGY; CONTROLLED STUDY; ENZYME ACTIVITY; GRIP STRENGTH; HYPERALGESIA; LIPID PEROXIDATION; MOTOR COORDINATION; MUSCLE HYPERALGESIA; NERVE CONDUCTION; NEUROPHYSIOLOGY; NEUROPROTECTION; NONHUMAN; PAIN THRESHOLD; PERIPHERAL NEUROPATHY; RAT; ROTAROD TEST; SCIATIC NERVE; TREATMENT DURATION; WATER IMMERSION; ANIMAL; ANIMAL BEHAVIOR; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; DRUG COMBINATION; DRUG EFFECT; METABOLISM; PATHOPHYSIOLOGY; PSYCHOMOTOR PERFORMANCE; SCIATIC NEUROPATHY;

ANIMALS; BEHAVIOR, ANIMAL; CATALASE; DISEASE MODELS, ANIMAL; DRUG THERAPY, COMBINATION; GLUTATHIONE; LIPID PEROXIDATION; NEURAL CONDUCTION; NEUROPROTECTIVE AGENTS; PERIPHERAL NERVOUS SYSTEM DISEASES; PSYCHOMOTOR PERFORMANCE; RATS; SCIATIC NEUROPATHY; SODIUM GLUTAMATE; STILBENES; THIOCTIC ACID; UBIQUINONE;

EID: 84896367881     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1155/2013/565813     Document Type: Article

References (33)

1. Hori K., Ozaki N., Suzuki S., Sugiura Y., Upregulations of P2X3 and ASIC3 involve in hyperalgesia induced by cisplatin administration in rats. Pain 2010 149 2 393 405 2-s2.0-77951767398 10.1016/j.pain.2010.03.005
2. Mollman J. E., Glover D. J., Hogan W. M., Furman R. E., Cisplatin neuropathy: risk factors, prognosis, and protection by WR-2721. Cancer 1988 61 11 2192 2195 2-s2.0-0023948344
3. Park S. B., Krishnan A. V., Lin C. S.-Y., Goldstein D., Friedlander M., Kiernan M. C., Mechanisms underlying chemotherapy-induced neurotoxicity and the potential for neuroprotective strategies. Current Medicinal Chemistry 2008 15 29 3081 3094 2-s2.0-60749134528 10.2174/092986708786848569
4. McDonald E. S., Randon K. R., Knight A., Windebank A. J., Cisplatin preferentially binds to DNA in dorsal root ganglion neurons in vitro and in vivo: a potential mechanism for neurotoxicity. Neurobiology of Disease 2005 18 2 305 313 2-s2.0-15944426735 10.1016/j.nbd.2004.09.013 (Pubitemid 40431114)
5. Alaedini A., Xiang Z., Kim H., Sung Y.-J., Latov N., Up-regulation of apoptosis and regeneration genes in the dorsal root ganglia during cisplatin treatment. Experimental Neurology 2008 210 2 368 374 2-s2.0-41149162713 10.1016/j.expneurol.2007.11.018
6. Pace A., Savarese A., Picardo M., Maresca V., Pacetti U., Del Monte G., Biroccio A., Leonetti C., Jandolo B., Cognetti F., Bove L., Neuroprotective effect of vitamin E supplementation in patients treated with cisplatin chemotherapy. Journal of Clinical Oncology 2003 21 5 927 931 2-s2.0-0037366026 10.1200/JCO.2003.05.139 (Pubitemid 46606454)
7. Kumar A., Kaundal R. K., Iyer S., Sharma S. S., Effects of resveratrol on nerve functions, oxidative stress and DNA fragmentation in experimental diabetic neuropathy. Life Sciences 2007 80 13 1236 1244 2-s2.0-33847334999 10.1016/j.lfs.2006.12.036 (Pubitemid 46329013)
8. Kim H. I., Kim T. H., Song J.-H., Resveratrol inhibits Na+ currents in rat dorsal root ganglion neurons. Brain Research 2005 1045 1-2 134 141 2-s2.0-19444384138 10.1016/j.brainres.2005.03.019 (Pubitemid 40725229)
9. Ernster L., Dallner G., Biochemical, physiological and medical aspects of ubiquinone function. Biochimica et Biophysica Acta 1995 1271 1 195 204 2-s2.0-0029042393 10.1016/0925-4439(95)00028-3
10. Littarru G. P., Langsjoen P., Coenzyme Q10 and statins: biochemical and clinical implications. Mitochondrion 2007 7 S168 S174 2-s2.0-34248170185 10.1016/j.mito.2007.03.002 (Pubitemid 46712232)
11. Galpern W. R., Cudkowicz M. E., Coenzyme Q treatment of neurodegenerative diseases of aging. Mitochondrion 2007 7 S146 S153 2-s2.0-34248207189 10.1016/j.mito.2007.01.004 (Pubitemid 46712231)
12. Shay K. P., Moreau R. F., Smith E. J., Smith A. R., Hagen T. M., Alpha-lipoic acid as a dietary supplement: molecular mechanisms and therapeutic potential. Biochimica et Biophysica Acta 2009 1790 10 1149 1160 2-s2.0-69949104384 10.1016/j.bbagen.2009.07.026
13. Packer L., Witt E. H., Tritschler H. J., Alpha-lipoic acid as a biological antioxidant. Free Radical Biology and Medicine 1995 19 2 227 250 2-s2.0-0029070687 10.1016/0891-5849(95)00017-R
14. Cairns B. E., Dong X., Mann M. K., Svensson P., Sessle B. J., Arendt-Nielsen L., McErlane K. M., Systemic administration of monosodium glutamate elevates intramuscular glutamate levels and sensitizes rat masseter muscle afferent fibers. Pain 2007 132 1-2 33 41 2-s2.0-34848813465 10.1016/j.pain.2007.01.023 (Pubitemid 47494557)
15. Burin D. G., Stoll B., Metabolic fate and function of dietary glutamate in the gut. The American Journal of Clinical Nutrition 2009 90 3 850S 856S
16. Boyle F. M., Wheeler H. R., Shenfield G. M., Amelioration of experimental cisplatin and paclitaxel neuropathy with glutamate. Journal of Neuro-Oncology 1999 41 2 107 116 2-s2.0-0032950178 10.1023/A:1006124917643 (Pubitemid 29161005)
17. Anjaneyulu M., Berent-Spillson A., Russell J. W., Metabotropic glutamate receptors (mGluRs) and diabetic neuropathy. Current Drug Targets 2008 9 1 85 93 2-s2.0-38849203708 10.2174/138945008783431772 (Pubitemid 351201683)
18. Arkaravichien T., Sattayasai N., Daduang S., Sattayasai J., Dose-dependent effects of glutamate in pyridoxine-induced neuropathy. Food and Chemical Toxicology 2003 41 10 1375 1380 2-s2.0-0141432142 10.1016/S0278- 6915(03)00142-X (Pubitemid 37289186)
19. Bianchi R., Brines M., Lauria G., Savino C., Gilardini A., Nicolini G., Rodriguez-Menendez V., Oggioni N., Canta A., Penza P., Lombardi R., Minoia C., Ronchi A., Cerami A., Ghezzi P., Cavaletti G., Protective effect of erythropoietin and its carbamylated derivative in experimental cisplatin peripheral neurotoxicity. Clinical Cancer Research 2006 12 8 2607 2612 2-s2.0-33646385600 10.1158/1078-0432.CCR-05-2177
20. Rybak L. P., Husain K., Whitworth C., Somani S. M., Dose dependent protection by lipoic acid against cisplatin-induced ototoxicity in rats: antioxidant defense system. Toxicological Sciences 1999 47 2 195 202 2-s2.0-0032938438 10.1093/toxsci/47.2.195 (Pubitemid 29214827)
21. Ishrat T., Khan M. B., Hoda M. N., Yousuf S., Ahmad M., Ansari M. A., Ahmad A. S., Islam F., Coenzyme Q10 modulates cognitive impairment against intracerebroventricular injection of streptozotocin in rats. Behavioural Brain Research 2006 171 1 9 16 2-s2.0-33646596554 10.1016/j.bbr.2006.03.009 (Pubitemid 43728393)
22. Necker R., Hellon R. F., Noxious thermal input from the rat tail: modulation by descending inhibitory influences. Pain 1978 4 231 242 (Pubitemid 8273226)
23. Ansari M. A., Ahmad S. J., Khanum R., Akhtar M., Pharmacological investigation of protective effects of Nigella sativa oil in experimental diabetic neuropathy in rats. Indian Journal of Pharmaceutical Education and Research 2009 43 2 166 176 2-s2.0-70350163797
24. Liasson S. G., Nerve conduction changes in experimental diabetes. Journal of Clinical Investigation 1964 43 12 2353 2358
25. Tiwari V., Kuhad A., Chopra K., Tocotrienol ameliorates behavioral and biochemical alterations in the rat model of alcoholic neuropathy. Pain 2009 145 1-2 129 135 2-s2.0-69049117166 10.1016/j.pain.2009.05.028
26. Jiang Y., Guo C., Vasko M. R., Kelley M. R., Implications of apurinic/apyrimidinic endonuclease in reactive oxygen signaling response after cisplatin treatment of dorsal root ganglion neurons. Cancer Research 2008 68 15 6425 6434 2-s2.0-51049100621 10.1158/0008-5472.CAN-08-1173
27. Van Doorn R., Leijdekkers C.-M., Henderson P. T., Synergistic effects of phorone on the hepatotoxicity of bromobenzene and paracetamol in mice. Toxicology 1978 11 3 225 233 2-s2.0-0018225140 (Pubitemid 9086116)
28. Aebi H., Catalase in vitro. Methods in Enzymology 1984 105 121 126 2-s2.0-0021318441 10.1016/S0076-6879(84)05016-3
29. Garcia J. M., Cata J. P., Dougherty P. M., Smith R. G., Ghrelin prevents cisplatin-induced mechanical hyperalgesia and cachexia. Endocrinology 2008 149 2 455 460 2-s2.0-38549087060 10.1210/en.2007-0828 (Pubitemid 351159314)
30. Kumar A., Sharma S. S., NF- B inhibitory action of resveratrol: a probable mechanism of neuroprotection in experimental diabetic neuropathy. Biochemical and Biophysical Research Communications 2010 394 2 360 365 2-s2.0-77950189559 10.1016/j.bbrc.2010.03.014
31. Melli G., Taiana M., Camozzi F., Triolo D., Podini P., Quattrini A., Taroni F., Lauria G., Alpha-lipoic acid prevents mitochondrial damage and neurotoxicity in experimental chemotherapy neuropathy. Experimental Neurology 2008 214 2 276 284 2-s2.0-56349134317 10.1016/j.expneurol.2008.08.013
32. Crane F. L., Hatefi Y., Lester C Widmer R. L., Isolation of a quinone from beef heart mitochondria. Biochimica et Biophysica Acta 1957 25 1 220 221
33. Crane F. L., Biochemical functions of coenzyme Q10. Journal of the American College of Nutrition 2001 20 6 591 598 2-s2.0-0035667921